BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10451139)

  • 1. Cisatracurium in a myasthenic patient undergoing thymectomy.
    Baraka A; Siddik S; Kawkabani N
    Can J Anaesth; 1999 Aug; 46(8):779-82. PubMed ID: 10451139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular interaction of sevoflurane--cisatracurium in a myasthenic patient.
    Baraka AS; Taha SK; Kawkabani NI
    Can J Anaesth; 2000 Jun; 47(6):562-5. PubMed ID: 10875720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
    Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
    Kopman AF; Kopman DJ; Ng J; Zank LM
    J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
    Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
    Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
    Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
    Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of atracurium in myasthenic patients undergoing thymectomy.
    Huang YG; Luo AL; Luo LK
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(2):102-6. PubMed ID: 2243832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients.
    Mann R; Blobner M; Jelen-Esselborn S; Busley R; Werner C
    Anesthesiology; 2000 Aug; 93(2):346-50. PubMed ID: 10910480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery.
    Hans P; Welter P; Dewandre PY; Brichant JF; Bonhomme V
    Acta Anaesthesiol Belg; 2004; 55(2):129-33. PubMed ID: 15264506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anesthesia and myasthenia gravis.
    Blichfeldt-Lauridsen L; Hansen BD
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):17-22. PubMed ID: 22091897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vecuronium block in the myasthenic patient. Influence of anticholinesterase therapy.
    Baraka A; Taha S; Yazbeck V; Rizkallah P
    Anaesthesia; 1993 Jul; 48(7):588-90. PubMed ID: 8102223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
    Suzuki T; Lien CA; Belmont MR; Tjan J; Savarese JJ
    Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anesthesia and myasthenia gravis.
    Baraka A
    Middle East J Anaesthesiol; 1993 Feb; 12(1):9-35. PubMed ID: 8316155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of cisatracurium in a case of myasthenia gravis].
    Rama-Maceiras P; Bonome C; Dávila M
    Rev Esp Anestesiol Reanim; 1998 Dec; 45(10):442-3. PubMed ID: 9927840
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognostic factors of myasthenic crisis after extended thymectomy in patients with generalized myasthenia gravis].
    Liu WB; Men LN; Tang BY; Huang RX
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2737-40. PubMed ID: 17199991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atracurium in the myasthenic patient.
    Bell CF; Florence AM; Hunter JM; Jones RS; Utting JE
    Anaesthesia; 1984 Oct; 39(10):961-8. PubMed ID: 6093617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonism of atracurium-induced block in obese patients.
    Kirkegaard-Nielsen H; Lindholm P; Petersen HS; Severinsen IK
    Can J Anaesth; 1998 Jan; 45(1):39-41. PubMed ID: 9466025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.